Long-term outcomes in adult patients below the age of 55 years with acute lymphoblastic leukemia treated with chemotherapy or allogeneic BM transplant in first CR

Saved in:
Bibliographic Details
Published inBone marrow transplantation (Basingstoke) Vol. 45; no. 7; pp. 1256 - 1258
Main Authors KOHLI, R, XU, W, BRANDWEIN, J, MINDEN, M. D, SCHIMMER, A, SCHUH, A. C, LIPTON, J. H, YEE, K, MESSNER, H. A, GUPTA, V
Format Journal Article
LanguageEnglish
Published Basingstoke Nature Publishing Group 01.07.2010
Subjects
Acute lymphoblastic leukemia
Acute lymphocytic leukemia
Adult
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Biological and medical sciences
Bone marrow
Bone Marrow Transplantation - methods
Bone marrow, stem cells transplantation. Graft versus host reaction
Cancer
Care and treatment
Chemotherapy
Health aspects
Hematologic and hematopoietic diseases
Humans
Leukemia
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Lymphatic leukemia
Medical sciences
Middle Aged
Patient outcomes
Polymerase chain reaction
Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy
Stem cell transplantation
Transfusions. Complications. Transfusion reactions. Cell and gene therapy
Transplantation
Transplantation, Homologous
Treatment Outcome
Young Adult
Canada
Human
Prognosis
Hematology
Malignant hemopathy
First complete remission
Long term
Chemotherapy
Treatment
Lymphoproliferative syndrome
Adult
Acute lymphocytic leukemia
Age
Cancer
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:0268-3369
1476-5365
DOI:10.1038/bmt.2009.324